---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-003584"
form_type: "8-K"
ticker: "CNBX"
cik: "0001343009"
company_name: "CNBX Pharmaceuticals Inc."
filed_at: "2022-05-13T23:59:59+00:00"
generated_at: "2026-06-25T16:30:08.736653+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# CNBX Pharma effects 1:120 reverse split and cuts authorized preferred to 5M shares

## Summary
- Reverse stock split of 1:120 effective May 12, 2022; par value unchanged.
- Authorized preferred shares reduced from 100,000,000 to 5,000,000.
- Common stock now trades on OTCQB under new symbol CNBXD; new CUSIP 13764M209.
- The reverse split was effected by filing a Certificate of Change with Nevada Secretary of State.

## SEC filing metadata
- accession: 0001683168-22-003584
- form_type: 8-K
- ticker: CNBX
- cik: 0001343009
- company_name: CNBX Pharmaceuticals Inc.
- filed_at: 2022-05-13T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1343009/000168316822003584/0001683168-22-003584-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1343009/000168316822003584/cnbx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-003584
- JSON: https://secwatch.observer/filing/0001683168-22-003584.json
- Plain text: https://secwatch.observer/filing/0001683168-22-003584.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.